Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-19-017955

Options or other derivatives

  • Director acquired 36,377 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
McGeorge Anne Director 2019-06-20 Grant or award · Stock Option (Right to Buy) +36,377 36,377 D
Loading xslF345X03/doc4.xml…